Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Neurobiol Learn Mem ; 131: 18-25, 2016 05.
Artigo em Inglês | MEDLINE | ID: mdl-26968655

RESUMO

Spermidine (SPD) is an endogenous aliphatic amine that modulates GluN2B-containing NMDA receptors and improves memory. Recent evidence suggests that systemic SPD improves the persistence of the long term memory of fear. However, the role of hippocampal polyamines and its binding sites in the persistence of fear memory is to be determined, as well as its putative underlying mechanisms. This study investigated whether the intrahippocampal (i.h.) infusion of spermidine or arcaine, modulators of polyamine binding site at GluN2B-containing NMDA receptors, alters the persistence of the memory of contextual fear conditioning task in rats. We also investigated whether protein synthesis and cAMP dependent protein kinase (PKA) play a role in SPD-induced improvement of the fear memory persistence. While 12h post-training infusion of spermidine facilitated, arcaine and the inhibitor of protein synthesis (anisomycin) impaired the memory of fear assessed 7days after training. The infusion of arcaine, anisomycin or a selective PKA inhibitor (H-89), at doses that have no effect on memory per se, prevented the SPD-induced improvement of memory persistence. H-89 prevented the stimulatory effect of SPD on phospho-PKA/total-PKA ratio. These results suggests that the improvement of fear memory persistence induced by spermidine involves GluN2B-containing NMDA receptors, PKA pathway and protein synthesis in rats.


Assuntos
Proteínas Quinases Dependentes de AMP Cíclico/metabolismo , Medo/fisiologia , Hipocampo/efeitos dos fármacos , Memória de Longo Prazo/efeitos dos fármacos , Nootrópicos/farmacologia , Poliaminas/metabolismo , Inibidores de Proteínas Quinases/farmacologia , Inibidores da Síntese de Proteínas/farmacologia , Espermidina/farmacologia , Animais , Anisomicina/administração & dosagem , Anisomicina/farmacologia , Comportamento Animal/efeitos dos fármacos , Comportamento Animal/fisiologia , Biguanidas/administração & dosagem , Biguanidas/farmacologia , Proteínas Quinases Dependentes de AMP Cíclico/antagonistas & inibidores , Isoquinolinas/administração & dosagem , Isoquinolinas/farmacologia , Masculino , Nootrópicos/administração & dosagem , Inibidores de Proteínas Quinases/administração & dosagem , Inibidores da Síntese de Proteínas/administração & dosagem , Ratos , Ratos Wistar , Espermidina/administração & dosagem , Sulfonamidas/administração & dosagem , Sulfonamidas/farmacologia
2.
Epilepsy Res ; 105(3): 396-400, 2013 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23602551

RESUMO

The present study aimed to investigate whether Na(+),K(+)-ATPase activity and phosphorylation state of the catalytic α subunit are altered by pentylenetetrazol (PTZ)-induced seizures. PTZ (30, 45 or 60 g/kg, i.p.) was administered to adult male Swiss mice, and Na(+),K(+)-ATPase activity and phosphorylation state were measured in the cerebral cortex 15 min after PTZ administration. Na(+),K(+)-ATPase activity significantly decreased after PTZ-induced seizures (60 mg/kg). Immunoreactivity of phosphorylated Ser943 at α subunit was increased after PTZ-induced seizures. A significant positive correlation between Na(+),K(+)-ATPase activity and latency to myoclonic jerks and generalized seizures was found. Conversely, a strong negative correlation between Ser943 phosphorylation and latency to generalized seizures was detected. Given the role of Na(+),K(+)-ATPase as a major regulator of brain excitability, Ser943 at Na(+),K(+)-ATPase α subunit may represent a potentially valuable new target for drug development for seizure disorders.


Assuntos
Córtex Cerebral/efeitos dos fármacos , Córtex Cerebral/enzimologia , Convulsivantes/toxicidade , Pentilenotetrazol/toxicidade , Convulsões/induzido quimicamente , ATPase Trocadora de Sódio-Potássio/metabolismo , Animais , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Masculino , Camundongos , Fosforilação/efeitos dos fármacos , Subunidades Proteicas/metabolismo , Tempo de Reação/efeitos dos fármacos , Convulsões/patologia , Serina/metabolismo , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA